Thank you for Subscribing to Med Tech Business Review Weekly Brief
Frank Ripullo II, Co-Founder and Managing Partner & Nancy Kailas, Co-Founder and Managing PartnerExcelerant Consulting has been named Medical Device Commercialization and GPO Strategy Service of the Year 2026, recognizing its expertise in helping medtech companies navigate complex group purchasing organization (GPO) and integrated delivery network (IDN) contracting. Excelerant helps clients understand the right contracting pathways, prepare for GPO and IDN engagement and use senior industry relationships to reach key stakeholders.
GPO and IDN strategy remain the foundation of Excelerant’s business. The firm complements this with commercialization support that improves readiness for contract award, acceptance and adoption. These services include market assessment and sizing, voice-of-customer (VOC) research, value analysis committee (VAC) readiness, distribution channel selection, government contracting strategy and independent sales representative (ISR).
Medical device manufacturers face significant commercialization challenges. Supply chain pressures, cost constraints, formulary standardization, SKU rationalization and complex purchasing decisions have made hospitals and health systems more selective. Even strong clinical innovations can struggle to gain traction without value analysis readiness, a clear GPO or IDN contracting strategy and the sales structure needed to drive adoption after securing access.
Excelerant Consulting helps medical device and healthcare technology companies navigate these challenges by connecting GPO and IDN strategy with the strategic work required to secure market access and build revenue.
Unlike firms that focus only on commercialization planning or GPO and IDN access, Excelerant integrates pre-market diligence, value readiness, GPO and IDN contracting, government contracting strategy, channel planning, distribution strategy and sales execution within one framework.
“Many medtech companies have strong products, but they are entering a healthcare market that is complex, expensive and difficult to navigate. Our role is to help clients think through the right strategy before they overinvest, so they can reduce risk, make smarter decisions and move forward with more confidence,” says Frank Ripullo II, co-founder and managing partner.
Excelerant gives clients access to senior commercial, contracting and national accounts expertise without the cost of building an internal national accounts team. The firm’s senior consultants bring more than 400 years of collective experience across GPOs, IDNs, provider organizations, distribution, government contracting and healthcare sales leadership.
This experience translates into measurable client outcomes. In one example, Excelerant helped an international healthcare technology company secure GPO and IDN opportunities in a competitive market. Within 120 days, the client completed an IDN corporate visit and initiated proof-of-concept trials. Six months later, it secured a contract providing access to approximately 185 healthcare facilities. Over the following five years, revenue grew from less than $1 million to $42 million.
Building GPO and IDN Contracting Strategy into the Commercial Plan
For many medical device companies, GPO and IDN access is critical to revenue growth. Contracting influences brand credibility, customer access and long-term growth. However, gaining access requires more than submitting an RFP and waiting for an award.
Excelerant helps companies understand where GPO, IDN and regional purchasing coalition (RPC) opportunities fit within their commercialization plan. This includes evaluating contract readiness, identifying purchasing pathways, preparing for stakeholder engagement and aligning sales strategy with contracting timelines.
Commercialization plans also account for GPO review cycles and IDN contracting requirements. When immediate GPO opportunities are not available, Excelerant helps clients pursue targeted IDN engagement strategies to maintain momentum until broader contracting opportunities develop.
Establishing Value Readiness for Market Adoption
Early-stage medical device companies often enter commercialization with strong clinical innovation but a limited understanding of healthcare purchasing decisions. Clinical benefits alone rarely secure approval. Value analysis committees assess financial impact, workflow implications, evidence quality, operational fit and long-term economic value before allowing products.
-
Our ability to bridge strategy and execution allows clients to move faster, reduce risk and achieve measurable commercial outcomes.
Excelerant strengthens market readiness through its Early-Stage Preparedness protocol, combining VOC research, healthcare landscape assessments and market-access analytics to create business plans informed by purchasing requirements.
The protocol also includes a value readiness assessment for value analysis committee reviews. Excelerant evaluates product positioning, clinical messaging, economic value drivers, supporting evidence and market-access readiness to develop value propositions for clinical, financial and operational stakeholders.
Supporting GPO and IDN Contract Administration
As commercialization expands, administrative requirements can become a significant burden. GPO and IDN contracts require accurate reporting, compliance oversight, administrative fee management and ongoing communication, which can quickly strain smaller teams.
Excelerant extends its commercialization support through ExcelTRAK, a proprietary solution that streamlines GPO and IDN contract administration, reporting and compliance.
ExcelLens, a reporting feature within the ExcelTRAK platform, provides visibility into sales by GPO affiliation, maps parent-child facility relationships and helps manage administrative fee obligations. Automated reporting reduces manual workloads and helps organizations avoid costs associated with late, incomplete or inaccurate submissions.
Dedicated ExcelAdmin support manages GPO and IDN contracts while leading RFI and RFP development, coordination and submission efforts.
Excelerant also refines its services through a learn, report and modify cycle, helping clients adapt to changing purchasing environments, contracting requirements and market conditions.
Connecting Market Access to Commercial Execution
Healthcare organizations increasingly standardize formularies, rationalize SKUs and scrutinize supply chain costs. These pressures make contract access important, but not sufficient on its own.
Complex IDN purchasing structures often involve multiple clinical, financial and operational stakeholders. Emerging companies may struggle to identify economic buyers, understand approval pathways or align value propositions with organizational priorities.
Excelerant helps clients connect market access strategy to commercial execution by defining customer targets, preparing for value analysis, aligning messaging to stakeholder priorities, building sales tools and supporting channel development.
“Our ability to bridge strategy and execution allows clients to move faster, reduce risk and achieve measurable commercial outcomes,” says Nancy Kailas, co-founder and managing partner.
The firm builds commercial models aligned with client growth objectives, including direct and independent sales representatives, distributors, clinical specialists and hybrid sales structures. Excelerant’s independent sales representative network expands market coverage without the cost and complexity of building a dedicated field organization.
Expanding Commercialization through Strategic Partnerships
Excelerant also helps clients pursue growth across commercial and government healthcare markets. GPOs and IDNs provide access to private, nonprofit and commercial healthcare systems. At the same time, federal healthcare networks represent meaningful opportunities for companies with the right strategy and readiness.
Excelerant provides strategic guidance for the Department of Defense, Federal Supply Schedule and Veterans Affairs health systems, helping clients navigate procurement requirements and integrate government contracting into their growth strategy.
Recognizing that commercialization often requires capabilities beyond market access and contracting, Excelerant has built strategic partnerships with The Clinician Exchange, JD Lymon, Kuro, Jevan Consulting and National MedSales Associates. These partnerships expand support across clinical services, coding and reimbursement, inventory management, executive advisory services and non-acute care representation.
Moving from innovation to commercial growth requires more than product development alone. It requires GPO and IDN strategy, value readiness, contracting expertise, customer access, sales execution and the ability to adapt as purchasing requirements change.
From VAC Readiness to Contract Access
A promising medical device can stall long before a clinician has a chance to champion it. The blockage usually sits inside the purchasing path. Value analysis committees want clinical rationale, economic proof, implementation clarity and a credible fit within current care routines before a new product earns time on an agenda. GPOs and IDNs add another layer of timing, hierarchy, contracting rules and member-system politics. For manufacturers, the issue is rarely invention alone. It is whether the commercial case is built early enough for hospital buyers who must defend standardization, budget impact, supplier risk and staff burden.
Commercialization support in this field has to begin before a launch calendar hardens. Early market work should test whether providers see the same use case the manufacturer sees, where the product fits in existing care routines, and what evidence will carry weight with economic buyers. A polished pitch is not enough when committees are measuring product claims against formularies, SKU reduction targets, supply chain pressure and staff capacity. Reimbursement logic, coding exposure, product education and evidence materials also shape the buying conversation, even when they sit outside the contract document. The stronger advisory partner helps find gaps before the hospital finds them.
"Excelerant Consulting is a strong choice for medical device companies that need commercialization advice tied directly to GPO/IDN pathways and government contracting."
Contract access creates a different test. A GPO award or IDN conversation may open a door, but it does not replace account strategy. Medical device teams need a practical map of who reviews the product, how a decision moves through the health system and what materials must be ready before the next contracting window. The work also has to account for aggregation groups and regional purchasing coalitions that can influence adoption outside the largest national channels. Government channels require separate fluency. VA Health, DoD, FSS and related federal pathways do not behave like commercial networks, so broad market-access language can leave a manufacturer underprepared for documentation, pricing review, agency process and follow-through after award.
The sales structure should be judged with the same discipline. A start-up may not need a large dedicated field force on day one. It may need direct coverage in certain accounts, independent representation in others, clinical education where product adoption depends on procedure change and reporting support once contracts begin producing volume. Administrative-fee reporting can become a hidden drag if sales data cannot be tied back to GPO affiliation or parent and child facility structures. The wrong structure burns cash before buying groups have accepted the product. The right structure connects access work to adoption work and keeps the post-award burden visible.
"The stronger advisory partner helps find gaps before the hospital finds them."
Excelerant Consulting is a strong choice for medical device companies that need commercialization advice tied directly to GPO/IDN pathways and government contracting. Its work spans early-stage preparedness, value readiness assessment, strategic planning, contracting support, sales force development and ExcelTRAK reporting for admin-fee and rebate management.
The firm’s model links product positioning to contract pursuit, channel design, field coverage, RFI/RFP support and post-award reporting rather than treating those pieces as disconnected work streams. For buyers weighing advisory partners, that continuity is the practical reason to put Excelerant Consulting at the top of the shortlist.
...Read more
Medical Device Commercialization and GPO Strategy Services Info
Q1
What Are Medical Device Commercialization and GPO Strategy Services?
Medical Device Commercialization and GPO Strategy Services help medical technology companies prepare products for successful adoption after development and regulatory milestones are complete. The work extends beyond launch planning to include commercialization strategy, value proposition development, market readiness assessments, healthcare contracting and support for engaging Group Purchasing Organizations (GPOs). These services also help companies understand purchasing expectations across healthcare systems so they can enter the market with stronger positioning, clearer commercial plans and fewer delays during the buying process.
Q2
How Does Excelerant Consulting Support Medical Device Commercialization and GPO Strategy Services?
Excelerant Consulting approaches Medical Device Commercialization and GPO Strategy Services by combining commercialization planning with practical market execution. Its work includes value readiness assessments, strategic commercialization planning, sales optimization and guidance for securing contracts with Group Purchasing Organizations (GPOs), Integrated Delivery Networks (IDNs) and Regional Purchasing Coalitions (RPCs). The company also works with specialized consulting partners to support medical device commercialization from early planning through contract execution and commercial growth.
Q3
Why Are Medical Device Commercialization and GPO Strategy Services Important Before a Product Launch?
Launching a medical device successfully requires more than regulatory clearance. Medical Device Commercialization and GPO Strategy Services help organizations define commercial messaging, prepare evidence that demonstrates clinical and financial value and develop healthcare contracting strategies before engaging hospitals and healthcare providers. Early preparation also gives commercial teams a clearer understanding of purchasing requirements, helping them navigate value analysis reviews and improve the chances of broader market adoption once the product reaches the market.
Q4
What Should Organizations Look for When Evaluating Medical Device Commercialization and GPO Strategy Services?
Choosing the right Medical Device Commercialization and GPO Strategy Services partner starts with experience across medical device commercialization, market access, healthcare contracting, sales execution and value analysis processes. Familiarity with Group Purchasing Organizations (GPOs), IDNs and healthcare procurement pathways is equally important. Organizations should also look for a consulting partner that can move beyond strategic recommendations and help implement commercialization plans, negotiate contracts and support commercial growth after launch.
Q5
How Does Excelerant Consulting Help Organizations Navigate Healthcare Purchasing Channels?
As part of its Medical Device Commercialization and GPO Strategy Services, Excelerant Consulting helps clients prepare products for Value Analysis Committees while developing commercialization strategies that support purchasing decisions. It also provides guidance for pursuing contracts with healthcare purchasing organizations, government agencies and enterprise customers. Its services extend to medical device commercialization, salesforce development, market research, customer insights and healthcare contracting, giving organizations practical support throughout the commercialization journey.
Q6
What Business Value Do Medical Device Commercialization and GPO Strategy Services Deliver?
Organizations use Medical Device Commercialization and GPO Strategy Services to create a more structured path from innovation to commercial success. Stronger medical device commercialization planning, better market positioning and well-prepared contracting strategies can reduce commercialization risk while improving access to healthcare buyers. Combined with support for Group Purchasing Organizations (GPOs), sales execution and long-term commercial planning, these services help companies enter competitive healthcare markets with greater confidence and a stronger foundation for sustainable growth.
Company : Excelerant Consulting
ManagementFrank Ripullo II, Co-Founder and Managing Partner & Nancy Kailas, Co-Founder and Managing Partner
